Dagmar Dilloo

Title: Dagmar Dilloo: Innovator in Genetic Engineering

Introduction

Dagmar Dilloo is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of genetic engineering, particularly through her innovative work with herpes virus vectors. Her research focuses on the introduction of heterologous genetic material into human and non-human animal cells.

Latest Patents

Dagmar Dilloo holds a patent for her invention titled "Herpes virus vectors and their uses." This patent describes a process for treating cells to introduce genetic material, which involves using a recombinant herpesviral vector that is an attenuated or replication-defective mutant. The process allows for the transduction of various cell types, including hemopoietic and malignant cells, to express the introduced genetic material. This technique has potential applications in modifying hemopoietic cells and generating tumor immunogens from malignant cells.

Career Highlights

Throughout her career, Dagmar Dilloo has demonstrated a commitment to advancing the field of genetic research. Her innovative approaches have opened new avenues for therapeutic applications, particularly in the treatment of diseases related to blood cells. Her work is recognized for its potential impact on medical science and biotechnology.

Collaborations

Dagmar has collaborated with notable professionals in her field, including Michael Edward Griffith Boursnell and Stephen Charles Inglis. These collaborations have contributed to the advancement of her research and the successful development of her patented techniques.

Conclusion

Dagmar Dilloo's contributions to genetic engineering through her innovative patent on herpes virus vectors highlight her role as a leading inventor in the field. Her work not only showcases her expertise but also promises to influence future therapeutic strategies.